Chemomab Therapeutics Statistics
Total Valuation
CMMB has a market cap or net worth of $19.61 million. The enterprise value is $6.05 million.
Market Cap | 19.61M |
Enterprise Value | 6.05M |
Important Dates
The last earnings date was Monday, March 3, 2025, before market open.
Earnings Date | Mar 3, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CMMB has 18.86 million shares outstanding. The number of shares has increased by 38.15% in one year.
Current Share Class | n/a |
Shares Outstanding | 18.86M |
Shares Change (YoY) | +38.15% |
Shares Change (QoQ) | +7.55% |
Owned by Insiders (%) | 15.80% |
Owned by Institutions (%) | 6.50% |
Float | 11.82M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.52 |
P/TBV Ratio | 1.48 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.02.
Current Ratio | 4.98 |
Quick Ratio | 4.96 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -91.34% and return on invested capital (ROIC) is -58.96%.
Return on Equity (ROE) | -91.34% |
Return on Assets (ROA) | -47.10% |
Return on Invested Capital (ROIC) | -58.96% |
Return on Capital Employed (ROCE) | -107.22% |
Revenue Per Employee | n/a |
Profits Per Employee | -$697,250 |
Employee Count | 20 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.50% in the last 52 weeks. The beta is 0.49, so CMMB's price volatility has been lower than the market average.
Beta (5Y) | 0.49 |
52-Week Price Change | +33.50% |
50-Day Moving Average | 1.66 |
200-Day Moving Average | 1.54 |
Relative Strength Index (RSI) | 29.32 |
Average Volume (20 Days) | 153,872 |
Short Selling Information
Short Interest | 269,535 |
Short Previous Month | 389,864 |
Short % of Shares Out | 1.44% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.31 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -14.74M |
Pretax Income | -19.36M |
Net Income | -13.95M |
EBITDA | -14.67M |
EBIT | -14.74M |
Earnings Per Share (EPS) | -$0.86 |
Balance Sheet
The company has $14.27 million in cash and $324,000 in debt, giving a net cash position of $13.94 million or $0.74 per share.
Cash & Cash Equivalents | 14.27M |
Total Debt | 324,000 |
Net Cash | 13.94M |
Net Cash Per Share | $0.74 |
Equity (Book Value) | 13.54M |
Book Value Per Share | 0.72 |
Working Capital | 12.82M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CMMB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -38.15% |
Shareholder Yield | -38.15% |
Earnings Yield | -69.77% |
FCF Yield | n/a |
Analyst Forecast
The average price target for CMMB is $9.00, which is 765.39% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $9.00 |
Price Target Difference | 765.39% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -58.80% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |